Profitability
Weight: 15%
D-
30
- 5yr Avg ROIC -43.4%
- Operating Margin Trend +115.12 pp/yr
ADCT
ADC Therapeutics S.A.
AlphaQuality composite grade, weighted for high-growth software businesses.
⚠ 5 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a high-growth software business.
Grade overrides the 28.5 pillar composite — hard gates always win.
Capital Efficiency
Weight: 15%
F
0
- 5yr Avg ROE -168.1%
- 5yr Share-Count CAGR 14.2%
Growth Quality
Weight: 35%
C+
60
- Revenue-Growth Years (5) 3/5
Cash Generation
Weight: 20%
F
0
- 5yr FCF Margin -259.5%
- 5yr FCF/NI Conversion 0.00x
Balance Sheet
Weight: 10%
F
0
- Net Debt / EBITDA 10.00x
- Interest Coverage (EBIT/Int) -1.77x
- Altman Z-Score -6.69
Stability
Weight: 5%
C+
61
- Negative-Revenue Years (5) 1/5
- Piotroski F-Score 4
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.0 of 2 gurus held; 2 full exits.
- Holders
- 0 -2
- Avg Δ position
- —
- New buys
- 0
- Full exits
- 2